Skip to content

Arrow Radial Artery Catheterization Set

by Arrow Intl., Inc.

510(k) K810675

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

3 ongoing

This device is named in the recall

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK810675 Date27 Mar 1981ClearedStatusActive

Recalls

32 recalls · 3 ongoing · FDA

    • Ongoing Z-2397-2026 FDA Class I initiated 21 Apr 2026

    Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.

    • Ongoing Z-3299-2024 FDA Class II initiated 26 Jul 2024

    Reports have been received regarding open seals on the packaging.

    • Ongoing Z-0844-2020 FDA Class II initiated 12 Dec 2019

    The lidstock label incorrectly displays a MR (Magnetic Resonance ) Conditional symbol (instead of a MR Unsafe symbol) in reference to a component of the kit

  • 6 recalls, same reason

    • Terminated Z-1971-2018 FDA Class II initiated 11 Apr 2018
    • Terminated Z-1972-2018 FDA Class II initiated 11 Apr 2018
    • Terminated Z-1969-2018 FDA Class II initiated 11 Apr 2018
    • Terminated Z-1970-2018 FDA Class II initiated 11 Apr 2018
    • Terminated Z-1968-2018 FDA Class II initiated 11 Apr 2018
    • Terminated Z-2019-2018 FDA Class II initiated 11 Apr 2018

    Product sterility may be compromised due to unsealed packaging.

    • Terminated Z-1330-2018 FDA Class II initiated 22 Dec 2017

    Certain lots of cardiovascular catheters may not be completely sealed and so sterility of the product cannot be guaranteed.

  • 6 recalls, same reason

    • Terminated Z-1284-2018 FDA Class II initiated 26 Oct 2017
    • Terminated Z-1285-2018 FDA Class II initiated 26 Oct 2017
    • Terminated Z-1286-2018 FDA Class II initiated 26 Oct 2017
    • Terminated Z-1283-2018 FDA Class II initiated 26 Oct 2017
    • Terminated Z-1282-2018 FDA Class II initiated 26 Oct 2017
    • Terminated Z-1281-2018 FDA Class II initiated 26 Oct 2017

    The povidone iodine prep pads included in certain kits and trays do not meet the requirements for a 36-month shelf life and should be labeled with a 24-month shelf life.

    • Terminated Z-0486-2018 FDA Class II initiated 10 Jul 2017 on shared 510(k) K810675

    Needle supplier indicated the presence of loose polypropylene foreign matter above release specification.

    • Terminated Z-2327-2017 FDA Class II initiated 9 May 2017

    Arrow International is recalling the affected product because the packaging may not be completely sealed, which may compromise sterility.

  • 2 recalls, same reason

    • Terminated Z-2740-2016 FDA Class II initiated 8 Aug 2016
    • Terminated Z-2741-2016 FDA Class II initiated 8 Aug 2016

    Shipping carton labeling error.

  • 2 recalls, same reason

    • Terminated Z-2201-2016 FDA Class II initiated 2 Jun 2016
    • Terminated Z-2202-2016 FDA Class II initiated 2 Jun 2016

    Labeling error. Some shipping cartons labeled as ASK-04018-VUH contained ASK-04020-VUH kits; and some shipping cartons labeled as ASK-04020-VUH contained ASK-04018-VUH kits.

    • Terminated Z-0066-2015 FDA Class II initiated 6 Aug 2014 on shared 510(k) K810675

    The component supplier recalled their 0.9% Sodium Chloride Injection USP BD Posiflush SF Saline Flush Syringe 10mL because some unit packages may exhibit open seals which impact package integrity and potentially product sterility.

  • 7 recalls, same reason

    • Terminated Z-1359-2011 FDA Unclassified (pre-2012) initiated 29 Oct 2010
    • Terminated Z-1357-2011 FDA Unclassified (pre-2012) initiated 29 Oct 2010
    • Terminated Z-1356-2011 FDA Unclassified (pre-2012) initiated 29 Oct 2010
    • Terminated Z-1355-2011 FDA Unclassified (pre-2012) initiated 29 Oct 2010
    • Terminated Z-1346-2011 FDA Unclassified (pre-2012) initiated 29 Oct 2010
    • Terminated Z-1360-2011 FDA Unclassified (pre-2012) initiated 29 Oct 2010
    • Terminated Z-1358-2011 FDA Unclassified (pre-2012) initiated 29 Oct 2010

    Sterility may be compromised.

  • 2 recalls, same reason

    • Terminated Z-2495-2010 FDA Unclassified (pre-2012) initiated 29 Jul 2010
    • Terminated Z-2494-2010 FDA Unclassified (pre-2012) initiated 29 Jul 2010

    Incorrectly assembled 18 Ga x 2 1/2 Introducer Needle

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DQX
Device Class
Class II
Regulation
21 CFR Part 870.1330
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Other devices from Arrow Intl., Inc.

See all devices from Arrow Intl., Inc. →